Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 07, 2026 07:30 ET | Source: Creative Realities

Creative Realities Launches Digital Drive-Thru 2.0, a Modular, Scalable Solution Designed to Improve Drive-Thru Efficiency and Flexibility

LOUISVILLE, Ky., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech...
January 07, 2026 07:30 ET | Source: Anterix Inc.

Anterix Appoints Ross Spero as Chief Product Officer

WOODLAND PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Anterix, Inc. (NASDAQ: ATEX) today announced the appointment of Ross Spero as Chief Product Officer. Spero will lead Anterix’s product...
January 07, 2026 07:30 ET | Source: Palvella Therapeutics Inc.

Palvella Therapeutics Strengthens Leadership Team with Appointment of Veteran Medical Affairs Leader Vimal Patel, PharmD, as Senior Vice President of Medical Affairs

Seasoned dermatology and immunology executive brings more than 25 years of experience advancing and launching innovative therapies, including OPZELURA®, povorcitinib, ILUMYA®, ODOMZO®, REMICADE®, and...
January 07, 2026 07:30 ET | Source: Vera Therapeutics

Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy

Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy
January 07, 2026 07:30 ET | Source: FibroGen, Inc.

FibroGen Rebrands as Kyntra Bio to Reflect a New Era of Focus and Momentum

Name change to Kyntra Bio reflects the newly sharpened focus of the Company on novel therapies with potential for outsized impact in oncology and rare diseaseKyntra Bio will begin trading on Nasdaq...
January 07, 2026 07:30 ET | Source: Dyne Therapeutics, Inc.

Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically...
January 07, 2026 07:30 ET | Source: TG Therapeutics, Inc.

TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will present at the 44th...
January 07, 2026 07:30 ET | Source: Sotera Health Services, LLC

Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference

Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 07, 2026 07:30 ET | Source: TappAlpha

TappAlpha and Tuttle Capital Launch the T² Lift™ Series with TSYX and TDAX — Light-Leverage Versions of TSPY and TDAQ Designed to Offer 30% More Exposure to Growth + Income

TappAlpha and Tuttle Capital Launch the T² Lift™ Series with TSYX and TDAX
January 07, 2026 07:30 ET | Source: Intellia Therapeutics, Inc.

Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based...